Retinoblastoma binding protein 7, chromatin remodeling factor (RBBP7)
Target
RBBP7
Molecular classification
Chromatin remodeling factor, Histone-binding protein, WD-repeat protein family, Epigenetic regulator
01
Overview
Retinoblastoma binding protein 7 (RBBP7) is a ubiquitously expressed nuclear protein that belongs to the WD-repeat family, serving as a core component of multiple chromatin remodeling complexes. It is central to the regulation of chromatin assembly and histone modification, participating in complexes such as mSin3 co-repressor and nucleosome-remodeling factor (NURF). RBBP7 interacts directly with the tumor suppressor retinoblastoma protein (Rb), influencing cell proliferation, differentiation, and possibly tumorigenesis. The protein also has demonstrated interactions with BRCA1, indicating a potential role in DNA repair and cancer biology. RBBP7 is highly conserved and contributes to nuclear architecture and gene expression regulation via its epigenetic functions.
Other names
RB binding protein 7RBBP7RbAp46Histone-binding protein RBBP7
02
Mechanism of action
Indirect inhibition of complexes containing RBBP7, most commonly via histone deacetylase (HDAC) inhibition, resulting in altered transcriptional activity and cell cycle regulation.
03
Biological functions
Chromatin remodelingHistone modification (specifically, histone deacetylation via complex association)Regulation of cell proliferation and differentiationAssembly of chromatinComponent of various histone deacetylase complexes (e.g., mSin3 co-repressor complex)
04
Disease associations
Cancer (through interaction with retinoblastoma and BRCA1 proteins)Potential role in other proliferative or differentiation disorders (not extensively documented)Other (possible as part of wider chromatin-associated pathologies; limited explicit data)
05
Safety considerations
Direct safety data for RBBP7-targeted agents are unavailable.Safety concerns of HDAC inhibitors (the broader pathway) include myelosuppression, cardiac toxicity, and GI disturbances; these are indirect and not specific to RBBP7.Theoretical risks relate to disturbance of epigenetic regulation across multiple tissues, given the ubiquitous expression and function.
06
Interacting drugs
There are currently no well-characterized, direct drugs targeting RBBP7 as a sole agent. Instead, drugs targeting chromatin remodeling—as a general pathway—sometimes indirectly impact RBBP7 activity via HDAC or chromatin complex inhibition (e.g., HDAC inhibitors such as vorinostat or panobinostat). These do not specifically target RBBP7 but may affect complexes containing it. Direct clinical targeting of RBBP7 has not been documented.
07
Biomarkers
RBBP7 protein levels and complex association may be investigated as potential biomarkers in cancer, especially in retinoblastoma and related pathway dysregulation, but it is not established or widely used for patient selection or monitoringNo established clinical biomarker practice for RBBP7 at present
Beyond the preview
Go deeper on Retinoblastoma binding protein 7, chromatin remodeling factor (RBBP7).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Retinoblastoma binding protein 7, chromatin remodeling factor (RBBP7).